Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Ferrari NV (RACE) Price & Performance

ADMA Biologics IncTrade
Ferrari NVTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Ferrari NV — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while Ferrari NV trades at $408.36 (market cap $71.67B). The key difference: Ferrari NV is far larger — about 32.3× ADMA Biologics Inc's market cap, and Ferrari NV pays a 1.04% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.

ADMARACE
Market Cap
$2.22B$71.67B
Sector
HealthConsumer Cyclical
52-Week High
$20.38$504.09
52-Week Low
$7.60$314.63
Enterprise Value
$2.29B$73.60B
Dividend Yield
1.04%

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Ferrari NV

Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.

Read more on RACE